Clinical trials: Anisometropia, open to volunteers
Amblyopia
Psilocybin for Amblyopia - Targeting Critical Periods in Humans
The purpose of this study is to evaluate whether ingestion of a drug called psilocybin can increase the effectiveness of amblyopia therapy in adults with amblyopia.
- Trial name
- PATCH (NCT07920081)
- Testing
- Amblyopia Therapy, 1 mg Psilocybin, 5 mg Psilocybin
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Johns Hopkins University
Amblyopia, Anisometropia
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Amblyopia
This study is initiated and conducted by the Shanghai Eye Disease Prevention and Treatment Center / Shanghai Eye Hospital. Many people once believed that amblyopia (commonly known as "lazy eye") could only be treated during…
- Trial name
- NCT07764198
- Testing
- Gabor training
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Jiannan Huang
Myopia (Disorder), Anisometropia
Children Receiving Monocular MiSight® 1 Day Treatment for Unilateral Myopia
This investigator-initiated prospective observational cohort study aims to establish the first longitudinal clinical database evaluating fellow-eye myopia development in children receiving monocular MiSight® 1 Day treatment for…
- Trial name
- NCT07778264
- Testing
- MiSight® 1 Day
- Volunteers
- 100 people
- Sponsor
- Buddhist Tzu Chi General Hospital
Myopia, Astigmatism
The EYERISING Study
The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months.
- Conditions
- Myopia, Astigmatism, Anisometropia
- Trial name
- NCT07909720
- Testing
- Repeated Low-Level Red Light (RLRL) therapy
- Where
- 2 sites in United States, Nepal
- Volunteers
- 333 people
- Sponsor
- University of Wisconsin, Madison
Anisometropia, Hyperopia
Effect of Light-Blocking Lenses on Hyperopic Anisometropic Children
To evaluate the effectiveness of light-blocking lenses in promoting emmetropization and reducing anisometropia in children with hyperopic anisometropia, and to assess the impact of light-intercepting lenses on visual function in…
- Trial name
- NCT07142928
- Testing
- light-blocking lenses, single-vision lenses
- Where
- China
- Volunteers
- 90 people
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
Anisometropia, Myopia
Targeted Lens Intervention for Myopic Anisometropia in Children
The goal of this clinical trial is to learn if our research spectacles will lower the difference in prescription (spectacles degree) between the eyes in children between 6 to 13 years old with anisometropic myopia.
- Trial name
- NCT07533149
- Testing
- More myopic eye: MCL1; Less myopic eye: MCL2
- Where
- Singapore
- Volunteers
- 20 people
- Sponsor
- Essilor International
Myopia, Anisometropia
Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens
The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.
- Trial name
- NCT06744478
- Testing
- Misight 1 Day Contact Lens
- Where
- Taiwan
- Volunteers
- 50 people
- Sponsor
- Buddhist Tzu Chi General Hospital
Amblyopia, Strabismus
Attention-based Binocular Training for Impaired Stereopsis (BRAVE)
This study evaluates a novel attention-based binocular visual search training paradigm designed to improve stereopsis (stereo vision) in individuals with impaired binocular vision.
- Conditions
- Amblyopia, Strabismus, Anisometropia, Binocular Vision Abnormalities
- Trial name
- BRAVE (NCT07803458)
- Testing
- Attention-Guided Dichoptic Visual Search Training, Zero-Disparity Dichoptic Visual Search Task
- Where
- 2 sites in Hong Kong
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Centre for Eye and Vision Research
Anisometropic Amblyopia, Strabismic Amblyopia
3D Movie Viewing vs Occlusion for Treating Amblyopia in Children
Amblyopia is a common childhood visual disorder that affects vision in one eye and can also impair depth perception (stereopsis).
- Trial name
- VISTA3D (NCT07563946)
- Testing
- 3D Movie Viewing, Occlusion Therapy
- Volunteers
- 56 people
- Sponsor
- Universitat Politècnica de Catalunya